Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

US public investment in development of mRNA covid-19 vaccines: retrospective cohort study
Hussain S. Lalani, Sarosh Nagar, Ameet Sarpatwari, et al.
BMJ (2023), pp. e073747-e073747
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA
Peter Parry, Astrid Lefringhausen, Conny Turni, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2287-2287
Open Access | Times Cited: 51
The cost-effectiveness of vaccination against COVID-19 illness during the initial year of vaccination
Lisa A. Prosser, Janamarie Perroud, Grace S. Chung, et al.
Vaccine (2025) Vol. 48, pp. 126725-126725
Closed Access | Times Cited: 1
A half-century of research on tuberculosis: Successes and challenges
Barry R. Bloom
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 9
Open Access | Times Cited: 25
Financing covid-19 mRNA vaccines
Victor Roy
BMJ (2023), pp. p413-p413
Open Access | Times Cited: 23
COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, et al.
Cureus (2024)
Open Access | Times Cited: 13
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1112-1178
Closed Access | Times Cited: 6
Advancements in Melanoma Treatment: A Review of PD-1 Inhibitors, T-VEC, mRNA Vaccines, and Tumor-Infiltrating Lymphocyte Therapy in an Evolving Landscape of Immunotherapy
Apoorva Mehta, Mateen Motavaf, Ikenna David Nebo, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1200-1200
Open Access
Development and validation of the Oxford Benchmark Scale for Rating Vaccine Technologies (OBSRVT), a scale for assessing public attitudes to next-generation vaccine delivery technologies
Jonathan Kantor, Robert Carlisle, Samantha Vanderslott, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Fostering Marketplace Inclusion: Health Equity Implications
Monica LaBarge, Karen Block
Journal of Public Policy & Marketing (2025) Vol. 44, Iss. 2, pp. 237-239
Closed Access
Can the Revolution in mRNA-Based Vaccine Technologies Solve the Intractable Health Issues of Current Ruminant Production Systems?
Timothy J. Mahony, Tatiana Briody, Sheila C. Ommeh
Vaccines (2024) Vol. 12, Iss. 2, pp. 152-152
Open Access | Times Cited: 4
Why are our medicines so expensive? Spoiler: Not for the reasons you are being told…
Els Torreele
European Journal of General Practice (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 3
Project NextGen: Developing the Next Generation of Coronavirus Disease 2019 (COVID-19) Vaccines and Therapeutics to Respond to the Present and Prepare for the Future
Kimberly A. Hofmeyer, Christy L. Ventura, Kimberly L. Armstrong, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 1, pp. 115-121
Open Access | Times Cited: 3
Introduction to RNA Vaccines Post COVID-19
Thomas Kramps
Methods in molecular biology (2024), pp. 1-22
Closed Access | Times Cited: 2
Effects of prior knowledge and collaborations on R&D performance in times of urgency: the case of COVID‐19 vaccine development
Daniel Laufs, Tetyana Melnychuk, Carsten Schultz
R and D Management (2024) Vol. 54, Iss. 5, pp. 968-992
Open Access | Times Cited: 2
Global Health Law for a Safer and Fairer World
Sam Halabi, Lawrence O. Gostin, Olohikhuae Egbokhare, et al.
New England Journal of Medicine (2024) Vol. 390, Iss. 20, pp. 1925-1931
Closed Access | Times Cited: 1
Salud para todos: Transformar la economía para que proporcione lo que importa. Informe final del Consejo sobre los Aspectos Económicos de la Salud para Todos de la OMS
Organización Panamericana de la Salud
(2024)
Open Access | Times Cited: 1
‘Our project, your problem?’ A case study of the WHO’s mRNA technology transfer programme in South Africa
Matthew Herder, Ximena Benavides
PLOS Global Public Health (2024) Vol. 4, Iss. 9, pp. e0003173-e0003173
Open Access | Times Cited: 1
States of Health
Leslie P. Francis, John G. Francis
Oxford University Press eBooks (2024)
Closed Access | Times Cited: 1
Covid-19: Latin America defies nationalism and circumstance to develop its own vaccines
Martín De Ambrosio
BMJ (2023), pp. p1351-p1351
Open Access | Times Cited: 3
World-Class Innovation, but at What Cost? A Brief Examination of the American Healthcare System
Spencer Delfino, Andrew J. Larson, Daniel Haines, et al.
Cureus (2023)
Open Access | Times Cited: 2
How Scientists View Vaccine Hesitancy
Eric W. Welch, Timothy P. Johnson, Tipeng Chen, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1208-1208
Open Access | Times Cited: 2
Unveiling patenting strategies of therapeutics and vaccines: evergreening in the context of COVID-19 pandemic
María Lorena Bacigalupo, María F. Pignataro, Carolinne Thays Scopel, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 2
Association between COVID-19 Vaccination and SARS-CoV-2 Infection among Household Contacts of Infected Individuals: A Prospective Household Study in England
Khitam Muhsen, Pauline A. Waight, Freja Kirsebom, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 113-113
Open Access
Application of tele neuropsychology and tele mental health before and during COVID-19 era: A bibliometric analysis
Abraish Ali, Rameen Zafar, Kanwal Ashok Kumar, et al.
Annals of Medicine and Surgery (2024)
Open Access
Vaccine Science Diplomacy and “The Phenomenon of Man”
Peter J. Hotez
The Linacre Quarterly (2024) Vol. 91, Iss. 3, pp. 254-264
Open Access
Page 1 - Next Page

Scroll to top